Cell based assays for drug discovery in preclinical settings
Speed up your cellular assay development with reliable and reproducible solutions
Cell based assays are key to the development of novel immunotherapies or drugs. From target discovery to preclinical development, cell based assays help researchers to gain valuable mechanistic insight and ultimately select efficient and safe drug candidates. Depending on the scientific question, a variety of cellular assays are available as model systems – from cell lines to primary cells. Based on most-recent developments, the field is advancing from traditional 2D assays to 3D assay systems, enabling researchers to get a more patient-oriented view.
Establishing cell based assays for immuno-oncology (IO) can be cumbersome as it requires lots of optimization. Assays can also be highly variable making it difficult to interpret the data in a meaningful way. The use of non-standardized solutions, on top of operator or donor variabilities, adds further complexity. Miltenyi Biotec offers solutions for reproducible cell based assays from preparation and isolation of pure cell populations to different analytical options.
Solutions for wide-ranging cellular assay applications
From cell lines to different primary cells, we are providing high-quality tools and reagents for 2D cellular assays that can save you time, ensure reproducibility, and offer reliable results.
Cell viability and cytotoxicity assays
Cell activation, expansion, and polarization assays
T cell suppression assays
Automated technologies for cell based assays
Meet our cutting-edge technologies that cover your immuno-oncology cell based assay workflows from end-to-end. From preparing precious tissue material and other starting samples, to isolating specific cells of interest for your assay, as well as the 2D culture of different primary cells, and the analysis by highly automated flow cytometry or high-resolution 3D imaging – our technologies are your ideal choice.
Resources for cell based assays
Check out our webinars and application notes on various cell-based assays to gain insights into diverse immune cell responses involving, e.g., regulatory T cells, NK cells, and macrophages.
Webinar
Immunogenicity testing in drug development
Immunogenicity testing is critical in the early phase of drug development. Sofie Pattijn presents best practice examples in her webinar. Learn which in vitro assays work best for your expanded immune cells and find out how it can accelerate your drug development.
You have previously chosen International as your location.
What do you want to do?